We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.27B
AUM Growth
+$187M
Cap. Flow
-$201M
Cap. Flow %
-2.17%
Top 10 Hldgs %
8.81%
Holding
1,234
New
57
Increased
340
Reduced
328
Closed
245

Top Buys

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$18.1M
2
PLMR icon
Palomar
PLMR
+$13.4M
3
GCMG icon
GCM Grosvenor
GCMG
+$12.9M
4
ACA icon
Arcosa
ACA
+$11.8M
5
MIDD icon
Middleby
MIDD
+$10.2M

Sector Composition

Rank Sector Weight
1 Industrials 24.2%
2 Technology 21.11%
3 Financials 13.34%
4 Consumer Discretionary 12.55%
5 Healthcare 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCO icon
401
Ducommun
DCO
$2.7B
$6.71M 0.07%
203,795
+2,064
+1% +$74.2K
TTMI icon
402
TTM Technologies
TTMI
$12B
$6.7M 0.07%
587,303
+738
+0.1% +$8.63K
KMPR icon
403
Kemper
KMPR
$1.67B
$6.68M 0.07%
99,900
+1,200
+1% +$91.1K
FFG
404
DELISTED
FBL Financial Group
FFG
$6.67M 0.07%
138,452
-54,700
-28% -$2.18M
CMTL icon
405
Comtech Telecommunications
CMTL
$50.3M
$6.67M 0.07%
476,531
-3,656
-0.8% -$58.5K
AORT icon
406
Artivion
AORT
$1.3B
$6.62M 0.07%
358,158
+132,900
+59% +$2.54M
VWTR
407
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$6.61M 0.07%
738,073
-50,113
-6% -$433K
CAMT icon
408
Camtek
CAMT
$6.18B
$6.61M 0.07%
429,600
-30,000
-7% -$446K
CCS icon
409
Century Communities
CCS
$1.91B
$6.59M 0.07%
155,644
-10,500
-6% -$384K
ASPN icon
410
Aspen Aerogels
ASPN
$384M
$6.54M 0.07%
596,779
-29,581
-5% -$234K
UTHR icon
411
United Therapeutics
UTHR
$25.8B
$6.54M 0.07%
+64,700
New +$7.1M
VREX icon
412
Varex Imaging
VREX
$472M
$6.51M 0.07%
511,900
+109,194
+27% +$1.49M
NEO icon
413
NeoGenomics
NEO
$1.96B
$6.48M 0.07%
175,683
-13,500
-7% -$502K
SPCE icon
414
Virgin Galactic
SPCE
$328M
$6.48M 0.07%
16,848
APG icon
415
APi Group
APG
$17.1B
$6.47M 0.07%
682,500
+37,500
+6% +$345K
NPO icon
416
Enpro
NPO
$6.63B
$6.43M 0.07%
114,027
+48,500
+74% +$2.62M
SLGN icon
417
Silgan Holdings
SLGN
$4.23B
$6.41M 0.07%
174,442
+103,779
+147% +$3.8M
VIAV icon
418
Viavi Solutions
VIAV
$9.12B
$6.38M 0.07%
544,000
+419,000
+335% +$5.44M
PNTG icon
419
Pennant Group
PNTG
$1.4B
$6.37M 0.07%
165,233
-21,900
-12% -$671K
ATEC icon
420
Alphatec Holdings
ATEC
$1.46B
$6.37M 0.07%
958,836
+10,000
+1% +$56.4K
LIQT icon
421
LiqTech
LIQT
$23M
$6.3M 0.07%
93,170
+4,242
+5% +$234K
MHO icon
422
M/I Homes
MHO
$3.74B
$6.25M 0.07%
135,798
-46,500
-26% -$1.93M
AHRT
423
AH Realty Trust
AHRT
$529M
$6.23M 0.07%
673,188
+39,187
+6% +$386K
TFIN icon
424
Triumph Financial Inc
TFIN
$1.81B
$6.23M 0.07%
+200,146
New +$5.48M
SUPN icon
425
Supernus Pharmaceuticals
SUPN
$2.59B
$6.21M 0.07%
298,178
+51,149
+21% +$1.16M

Similar funds

Royce & Associates's Q3 2020 Portfolio in Review

As of Q3 2020, Royce & Associates held 1,234 positions worth $9.27B, up 2.1% from $9.08B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates's Q3 2020 filing shows 57 new, 340 increased, 328 reduced and 245 closed positions. Its largest new stake was Palomar: 136,247 shares worth $14.2M. The largest sale was Ares Management, an estimated $36.8M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2020 buy was Palomar: 136,247 shares worth $14.2M.
  • Royce & Associates added most to John B. Sanfilippo & Son in Q3 2020, an estimated $18.1M increase.
  • Royce & Associates's biggest Q3 2020 reduction was Ares Management, cutting an estimated $36.8M.
  • Royce & Associates fully exited Children's Place in Q3 2020, selling an estimated $11.2M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $9.27B portfolio in Q3 2020.
  • Royce & Associates opened 57 new positions and closed 245 in Q3 2020.
  • Royce & Associates's portfolio value rose 2.1% quarter-over-quarter to $9.27B.

Based on Royce & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.